TARGET
Device
Stryker Corporation
Total Payments
$2.8M
Transactions
5,747
Doctors
1,306
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $265,303 | 1,699 | 581 |
| 2023 | $547,463 | 1,470 | 526 |
| 2022 | $226,031 | 702 | 313 |
| 2021 | $315,410 | 680 | 212 |
| 2020 | $182,578 | 276 | 150 |
| 2019 | $547,050 | 547 | 254 |
| 2018 | $705,015 | 373 | 187 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.8M | 28 | 63.4% |
| Consulting Fee | $468,802 | 216 | 16.8% |
| Food and Beverage | $206,466 | 5,010 | 7.4% |
| Space rental or facility fees (teaching hospital only) | $191,843 | 45 | 6.9% |
| Travel and Lodging | $140,609 | 438 | 5.0% |
| Grant | $12,749 | 7 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $937.50 | 1 | 0.0% |
| Education | $183.28 | 2 | 0.0% |
Payments by Type
Research
$1.8M
28 transactions
General
$1.0M
5,719 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| IIS FEAT | Stryker Corporation | $629,130 | 0 |
| EFFECTIVENESS AND SAFETY OF SMALL ANEURYSM COILING TRIAL (NANO) | Stryker Corporation | $388,306 | 0 |
| TARGET | Stryker Corporation | $321,266 | 0 |
| NANO MS 7 ENROLLMENT OF 200 SUBJECTS | Stryker Corporation | $158,298 | 0 |
| ULTRA | Stryker Corporation | $109,716 | 0 |
| THE SURPASS INTRACRANIAL ANEURYSM EMBOLIZATION SYSTEM PIVOT TRIAL (SCENT) | Stryker Corporation | $54,525 | 0 |
| THE CITADEL EMBOLIZATION DEVICE FEASIBILITY STUDY | Stryker Corporation | $54,524 | 0 |
| PRO-PACK I | Stryker Corporation | $10,290 | 0 |
Top Doctors Receiving Payments for TARGET — Page 6
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Personal Emergency Response Attendant | Ellisville, MO | $933.02 | 11 |
| , M.D | Diagnostic Radiology | Ann Arbor, MI | $927.05 | 9 |
| , M.D | Student in an Organized Health Care Education/Training Program | Bronx, NY | $921.15 | 3 |
| , MD | Neurological Surgery | Chapel Hill, NC | $908.85 | 1 |
| , M.D | Vascular Neurology | Miami Beach, FL | $900.75 | 16 |
| , MD | Neurocritical Care | Los Angeles, CA | $897.81 | 9 |
| , M.D | Neurological Surgery | Miami, FL | $885.53 | 4 |
| , M.D | Neurological Surgery | Columbus, OH | $885.31 | 8 |
| , M.D., M.SC | Diagnostic Neuroimaging | San Francisco, CA | $885.11 | 16 |
| , MD, MS | Student in an Organized Health Care Education/Training Program | Gainesville, FL | $862.36 | 1 |
| , M.D | Neurological Surgery | Washington, DC | $834.76 | 7 |
| , MD | Neurology | Saint Louis, MO | $820.80 | 4 |
| , MD | Neurology | Mcallen, TX | $805.24 | 10 |
| , M.D | Neurological Surgery | Edison, NJ | $802.90 | 8 |
| , M.D | Otolaryngology | San Antonio, TX | $800.00 | 2 |
| , DO | Vascular Neurology | Harlingen, TX | $792.53 | 7 |
| , MD | Neurological Surgery | Cleveland, OH | $787.52 | 12 |
| , MD | Neurological Surgery | Corpus Christi, TX | $782.00 | 15 |
| , MD | Neurological Surgery | Grand Rapids, MI | $779.10 | 12 |
| , MD, MHA | Neurology | New Orleans, LA | $776.91 | 1 |
| , M.D | Diagnostic Radiology | Saint Louis, MO | $770.81 | 7 |
| , MD | Neuroradiology | Kansas City, KS | $764.31 | 6 |
| , MD | Neurological Surgery | Tallahassee, FL | $763.20 | 11 |
| , MD | Specialist | Plattsburgh, NY | $762.12 | 4 |
| , MBBS, MD | Internal Medicine | East Lansing, MI | $762.04 | 1 |
Ad
Manufacturing Companies
- Stryker Corporation $2.8M
Product Information
- Type Device
- Total Payments $2.8M
- Total Doctors 1,306
- Transactions 5,747
About TARGET
TARGET is a device associated with $2.8M in payments to 1,306 healthcare providers, recorded across 5,747 transactions in the CMS Open Payments database. The primary manufacturer is Stryker Corporation.
Payment data is available from 2018 to 2024. In 2024, $265,303 was paid across 1,699 transactions to 581 doctors.
The most common payment nature for TARGET is "Unspecified" ($1.8M, 63.4% of total).
TARGET is associated with 8 research studies, including "IIS FEAT" ($629,130).